Your browser doesn't support javascript.
loading
Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma.
Yang, Peiyu; Chen, Haimin; Liang, Xinyue; Xu, Weiling; Yu, Shanshan; Huang, Wenyang; Yi, Xingcheng; Guo, Qiang; Tian, Mengru; Yue, Tingting; Li, Mengyao; Zhang, Yingjie; Zhang, Mengxue; Yan, Yurong; Hu, Zhongli; Kumar, Shaji K; Zhou, Fan; Dai, Yun; Jin, Fengyan.
Afiliação
  • Yang P; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Chen H; Laboratory of Cancer Precision Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
  • Liang X; Department of Hematology and Oncology, Shanghai Jing'an District Zhabei Central Hospital, Shanghai, China.
  • Xu W; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Yu S; Radiology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Huang W; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Yi X; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China.
  • Guo Q; Laboratory of Cancer Precision Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
  • Tian M; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Yue T; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Li M; Laboratory of Cancer Precision Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
  • Zhang Y; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Zhang M; Laboratory of Cancer Precision Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
  • Yan Y; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Hu Z; Hematology Department, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Kumar SK; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Zhou F; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Dai Y; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Jin F; Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
Am J Hematol ; 98(2): 251-263, 2023 02.
Article em En | MEDLINE | ID: mdl-36309982
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China